Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19

Adrian Scutelnic1, Anita van de Munckhof2, Angel T Miraclin3

  • 1Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

PubMed

Insights

Patients with coronavirus disease 2019 associated cerebral venous thrombosis (COVID-CVT) showed similar mortality and functional outcomes compared to pre-pandemic controls. This international study found no significant difference in outcomes for COVID-CVT patients.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Vascular Medicine

Background:

  • Previous reports on COVID-19 associated cerebral venous thrombosis (COVID-CVT) suggested high mortality rates (up to 40%) based on small case series.
  • The clinical characteristics and outcomes of COVID-CVT require further investigation in larger, international cohorts.

Purpose of the Study:

  • To assess the clinical characteristics and outcomes of an international cohort of patients with COVID-CVT.
  • To compare the outcomes of COVID-CVT patients with a historical control group of cerebral venous thrombosis (CVT) patients.

Main Methods:

  • A registry study of consecutive COVID-CVT patients diagnosed between March 2020 and March 2023.
  • Utilized data from the International Cerebral Venous Thrombosis Consortium for comparison, including patients with CVT diagnosed between 2017 and 2018.
  • Outcome analyses were adjusted for age and sex.

Main Results:

  • Included 70 COVID-CVT patients from 23 hospitals in 15 countries and 206 controls.
  • COVID-CVT patients presented more frequently with altered mental state (44% vs 25%) and had a longer hospital stay (11 vs 8 days).
  • In-hospital mortality (7% vs 3%) and functional independence at 6 months (78% vs 87%) did not significantly differ between groups.

Conclusions:

  • Contrary to prior small studies, this international cohort found no significant difference in in-hospital mortality between COVID-CVT patients and pre-COVID-19 controls.
  • Functional outcomes at 6-month follow-up were also comparable between the COVID-CVT group and the historical control group.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
269
Veins of Head and Neck01:19

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
1.8K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
885
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
206
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60